← Open Payments lookup

MARIA TSAO: Open Payments

NPI 1336257278 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,851 in 75 payments from 10 companies in 2025. Trend: 2023 $2,527 · 2024 $2,568 · 2025 $2,851

Food & beverage: $2,851
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$596
Vanda Pharmaceuticals Inc.11$477
Otsuka America Pharmaceutical, Inc.15$419
E.R. Squibb & Sons, L.L.C.6$309
Neurocrine BioSciences, Inc.11$293
ABBVIE INC.7$280
Alkermes, Inc.7$170
Janssen Pharmaceuticals, Inc5$150
Axsome Therapeutics, Inc.1$119
Teva Pharmaceuticals USA, Inc.2$38

Products named: CAPLYTA, FANAPT, COBENFY, INGREZZA, ABILIFY MAINTENA, VRAYLAR, INVEGA SUSTENNA, HETLIOZ.

Industry payments across VA — which companies pay providers there.